GRENOBLE, France - July 1, 2026 - Diabeloop, a pioneer in therapeutic AI, today announced the launch of a new, highly ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2026 financial results ...

The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM sensor in ...

The 501(c)3 non-profit Tidepool, which seeks to empower the next generation of innovations in diabetes management, has announced that the US Food and Drug Administration (FDA) has cleared Tidepool ...

Introduction: Automated insulin delivery (AID) systems have become a standard of care in type 1 diabetes and are increasingly used across all age groups, including during pregnanc ...

With an initial indication for type 2 diabetes, SaMD developer UpDoc says its platform is designed to support doctors, not ...

TAR 2.0 is likely the most widely used analytic technology for reviewing large document collections for production (although ...

MiniMed MMED recently announced the commercial launch of its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' ABT Instinct sensor and the MiniMed Go system ...

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the commercial launch in Europe of both the ...

NORTHRIDGE, Calif. – MiniMed has announced its first commercial launch of the MiniMed Flex system in the United States – the company’s first app-controlled pump and its smallest insulin pump yet. The ...

MiniMed , today announced its first commercial launch of the MiniMed Flextm system in the United States ? its first app-controlled pump and the company's smallest insulin pump yet. The system launches ...

Control-IQ+ is an automated insulin delivery system used in Tandem's t:slim X2 and Mobi insulin pumps. The algorithm adjusts basal insulin every five minutes to prevent highs and lows. Automatic ...